What should you know about long-term effects of immunotherapy?

Immunotherapy stimulates immune activity against cancer, and that activity can sometimes remain directed at healthy tissue. Effects may begin during treatment or after an interval, and some settle while others require prolonged monitoring or replacement treatment. The risk depends on the medicine, dose, cancer type, previous treatment and individual health.

Possible changes include diarrhoea or abdominal pain, cough or breathlessness, yellowing of the skin, unusual fatigue, rash, joint pain, headaches, altered vision, or changes in thirst and urination. A symptom may have many causes, so the timing and pattern matter.

Keep your immunotherapy record and show it to every healthcare professional, including dentists and emergency clinicians. Report new symptoms early, even if treatment has finished. Attend blood tests and hormone checks when arranged, and take steroid or replacement medicines exactly as directed. Do not restart supplements or immune-stimulating products without checking with the oncology team.

Your treatment may have been used for bladder, cervical, bowel, head and neck, liver, lung cancer, lymphoma or melanoma. The cancer type and immunotherapy medicine determine which follow-up checks are relevant.

Seek urgent help for severe breathlessness, chest pain, confusion, fainting, severe weakness, uncontrolled diarrhoea, blood in stool, yellow skin, or a sudden reduction in urine. New severe headache, weakness on one side, seizure, or major vision change also needs emergency assessment. Tell the team that you have received immunotherapy.

Ask which organs were monitored during your treatment, which symptoms may appear later, and how long checks should continue. Clarify who to contact outside clinic hours, whether hormone replacement is needed, and which medicines could worsen immune-related inflammation.